Skip to content
Home/Companies/Healthcare / Medtech/HighLife
HighLife

HighLife

Healthcare / Medtech·France·Active·11yr hold
Entry
2015
Hold
11yr
Status
Active

Who owns HighLife?

HighLife is currently owned by Sofinnova Partners through Sofinnova Capital VIII (2015 vintage), since 2015.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Capital VIII · 2015 · Life Sciences VC

Key facts

HQFrance
SectorHealthcare / Medtech
Websitewww.highlifemedical.com

More from Sofinnova Capital VIII

Other portfolio companies in the same fund.

VectivBio
Exited 2023
BiotechSwitzerland· 2017
to
Breath Therapeutics
Exited 2019
BiotechGermany· 2016
to
Corvidia Therapeutics
Exited 2020
BiotechUS· 2016
to
Delinia
Exited 2017
BiotechUK· 2016
to
ENYO Pharma
ENYO Pharma
Active
BiotechFrance· 2016
ReCor Medical
Exited 2018
MedTechUS· 2016
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Biocomposites
Biocomposites
Active
TA AssociatesUS
CMR Surgical
CMR Surgical
Active
LightrockUK
Neuromod Devices
Neuromod Devices
Active
Enterprise IrelandIreland
Optos
Exited 2015
Amadeus Capital PartnersUK
to
Ardos
Active
Delphinus Venture CapitalDenmark· 2026
Axomove
Axomove
Active
Go CapitalFrance· 2026
Track HighLife

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy HighLife?

0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on HighLife.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue